gvtcx

Managed Service Contract for Viral Molecular Pathology Testing

University Hospitals Birmingham NHS Foundation Trust Published 16 Oct 2017 Contracts Finder

key details

Value£300,000
Statusplanned
Category (CPV) 38000000
RegionWest Midlands
Contract start8 Jan 2018
Contract end7 Jan 2021
SME suitableNo
OCIDocds-b5fd17-78aea189-7382-4e24-9a29-83726029a0e8

description

The Molecular Pathology Diagnostic Service (MPDS) is looking to advertise provision of a managed service (MSC) encompassing EGFR, BRAF, KRAS and NRAS testing over a range of cancer types.

The trust will be looking at solutions to provide equipment and reagents for the molecular testing of clinically relevant mutations in EGFR, BRAF, KRAS and NRAS from DNA extracted from formalin fixed paraffin embedded tissue and circulating tumour DNA from plasma.

There is an expectation that the FFPE DNA used in the tests above may be required in subsequent tests not covered by this managed service therefore provision for DNA extraction from FFPE material is not included within the scope of this MSC and supplied solutions for the assays required must be agnostic of DNA extraction methods used.

Extraction and testing of circulating tumour DNA from plasma for use in EGFR mutation testing will be included in the scope of the MSC.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
16 Oct 2017 Planning (planning) · 2692f10f-e2db-425d-b6b7-358b3c1b03de-176546

more from University Hospitals Birmingham NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.